Drugs / Inactivated Enterovirus Type 71 Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01273246 | Jan → Jun 2011 | hand, foot and mouth disease | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
| Phase 1 | NCT01273233 | Dec 2010 → Feb 2011 | enterovirus infectious disease | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Enterovirus Type 71 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01273246 ↗ |
| Modality | Vaccine | “The novel human EV71 inactivated vaccine was well tolerated and highly immunogenic in healthy volunteers, especially in infant populations.” PMID 22426327 ↗ Mar 2012 |
| Route | Intramuscular | “Adults received intramuscular injection on Days 0, 14 and 28.” PMID 22426327 ↗ Mar 2012 |